<DOC>
	<DOCNO>NCT00824863</DOCNO>
	<brief_summary>Pityrosporum folliculitis present fine superficial follicular pustule papules trunk upper extremity . Ketoconazole 2 % foam recently approve treatment seborrheic dermatitis immunocompetent patient 12 year old . Ketoconazole 2 % foam felt work reduce number pityrosporum yeast organism . Safety efficacy ketoconazole 2 % foam treatment fungal infection establish . This study demonstrate efficacy safety treatment pityrosporum folliculitis .</brief_summary>
	<brief_title>Safety Efficacy Ketoconazole 2 % Foam Treatment Pityrosporum Folliculitis</brief_title>
	<detailed_description>Malassezia/pityrosporum species ubiquitous saprophyte human skin . This organism implicate etiology seborrheic dermatitis , tinea versicolor , pityrosporum folliculitis . The prevalence pityrosporum folliculitis especially high warm humid environment , although presence universal . Pityrosporum folliculitis present immuno-competent , acne-prone young adult fine superficial follicular pustule papules trunk upper extremity . There comedo . This acneiform condition non-scarring . It cause significant morbidity patient frequently mistake acne vulgaris scar potential , often associate pruritis , fail respond adequate conventional acne treatment- systemic antibiotic , topical benzoyl peroxide , topical retinoids . Pityrosporum folliculitis sole present condition coexist acne vulgaris . Less commonly , patient pityrosporum folliculitis present associate tinea versicolor seborrheic dermatitis . The diagnosis make clinical presentation , microscopic examination pustule spores/hyphae , skin biopsy , retrospectively follow good response antimycotic therapy . Ketoconazole 2 % foam recently approve treatment seborrheic dermatitis immunocompetent patient 12 year old . Safety efficacy ketoconazole 2 % foam treatment pityrosporum folliculitis establish . Prior availability ketoconazole 2 % foam , successful treatment pityrosporum folliculitis require systemic anti fungal drug ketoconazole , itraconazole fluconazole . It also respond oral isotretinoin . Systemic antimycotic effective repeat use drug incur safety concern include hepatotoxicity drug-drug interaction . Oral isotretinoin indicate severe nodulo-cystic acne generally inappropriate routine treatment modality pityrosporum folliculitis . As pityrosporum folliculitis non-scarring acneiform condition recurrent , effective safe , patient initiated topical treatment would appropriate form therapy.The objective study demonstrate ketoconazole 2 % foam may treatment choice pityrosporum folliculitis .</detailed_description>
	<mesh_term>Folliculitis</mesh_term>
	<mesh_term>Ketoconazole</mesh_term>
	<criteria>1 . Diagnosis pityrosporum folliculitis establish clinical presentation fine , superficial follicular papule pustule chest , back , upper arm . KOH do pustule look spore hyphae . 2 . Concomitant acne treatment standard acne treatment modality allow oral topical antibiotic , topical retinoids , benzoyl peroxide . 1 . Pregnancy breast feed 2 . Patients nodulocystic acne trunk 3 . Current prior treatment oral isotretinoin 4 . Patients allergic ketoconazole topical foam product 5 . Patients associate serious systemic disease immunocompromised patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>pityrosporum folliculitis</keyword>
	<keyword>ketoconazole 2 % foam</keyword>
</DOC>